The efficacy and safety of endo‐radiofrequency for the treatment of hidradenitis suppurativa
Skin Research and Technology · 2023
DOI: 10.1111/srt.13450 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Skin Research and Technology, 2023. Verfasst von Elham Behrangi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical …. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Patient Satisfaction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hidradenitis suppurativa (HS) is a chronic and recurrent disease of the axilla and groin with inflammatory lesions. There is no definitive medication or intervention to cure the disease. Radiofrequency (RF) is a modality to destroy the lesions by transferring heat into the skin. To date, few studies have been conducted to evaluate the efficacy and safety of RF at HS.
Methods
This 9‐month, prospective, nonrandomized, and single‐blinded study is a clinical trial conducted in 10 patients with refractory HS. In all patients, the initial grade of HS was evaluated. The procedure involved treating HS of the axilla with a endo‐RF wave device. Post‐treatment evaluation included: determination of the severity of the disease by a blinded dermatologist, the degree of patient satisfaction, tolerability in each patient, and complications of the procedure. We also evaluate the recurrence of the disease during a 6‐month follow‐up.
Results
The satisfaction level after the intervention among under‐studied cases was excellent and good in six of cases. There was a significant difference in comparing the grading score of patients before and 3 months after receiving RF ( P ‐value: 0.01). Regarding tolerability, eight of the patients could tolerate it. We had no complication after the intervention and four cases had not recurrence during a 6‐month follow‐up.
Conclusion
Endo‐RF is an effective and safe modality for treating HS however to prevent the recurrence, periodic therapy sessions are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.
- Tehran University of Medical Sciences, Tehran, Iran.
- Yoosefabad Skin and Hair Center, Tehran, Iran.
ORCID-Profile: Elaheh Lotfi
Zitieren
APA
Behrangi, E., Atefi, N., Mireshghollah, P., Goodarzi, A., Dehghani, A., Zare Dehnavi, A., Roohaninasab, M., Dilmaghani, S., & Lotfi, E. (2023). The efficacy and safety of endo‐radiofrequency for the treatment of hidradenitis suppurativa. Skin Research and Technology. https://doi.org/10.1111/srt.13450
Vancouver
Behrangi E, Atefi N, Mireshghollah P, Goodarzi A, Dehghani A, Zare Dehnavi A, et al. The efficacy and safety of endo‐radiofrequency for the treatment of hidradenitis suppurativa. Skin Research and Technology. 2023. doi:10.1111/srt.13450
BibTeX
@article{Behrangi2023,
author = {Behrangi, Elham and Atefi, Najmolsadat and Mireshghollah, Pardissadat and Goodarzi, Azadeh and Dehghani, Abbas and Zare Dehnavi, Ali and Roohaninasab, Masoumeh and Dilmaghani, Sara and Lotfi, Elaheh},
title = {The efficacy and safety of endo‐radiofrequency for the treatment of hidradenitis suppurativa},
journal = {Skin Research and Technology},
year = {2023},
doi = {10.1111/srt.13450}
}
EUVIMED